Monograph
D01AC10 - Bifonazole |
Propably not porphyrinogenic |
PNP |
Rationale
Inhibitor of CYPs 17 (potent), C19 (aromatase), 2E1, 11B1 and 3A4. Probably insignificant systemic exposure.
Chemical description
Imidazole antimycotic for dermatological use (creme 1%). Inhibitor of several CYPs. Systemic absorbtion from the skin is very low; 0.6-0.8 %.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Mycospor, creme o/w 10 mg/g 
Canestene Derm · Canestene Derm 1 % cr?me 
CANESMYCOSPOR 10 mg/g CREMA · CANESMYCOSPOR ONICOSET 10mg/ g + 400mg/g POMADA · CANESPIE BIFONAZOL 10 mg/g CREMA · CANESPIE BIFONAZOL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA · Levelina · LEVELINA 10 mg/g CREMA · LEVELINA 10 mg/g POLVO CUTANEO 
BIAZOL 10 mg/g · CANESPOR 10 mg/g · CANESPOR 10 mg/ml 
Canesten Bifonazole Once Daily Athlete's Foot 
Canespor · Steper pro 
Canestene Derm 
Canespor 
Canespor®
© NAPOS 2025